Audax Private Equity Invests in Team Cymru

Audax Private Equity Acquires Majority Stake in Flashpoint

July 21, 2021

Cybersecurity

Audax Private Equity acquired a majority stake in Flashpoint, a New York–based provider of actionable threat intelligence and intelligence automation, in July 2021. Terms were not disclosed; Audax said the investment will support Flashpoint’s product development, organic growth and buy‑and‑build/inorganic expansion to broaden its cyber intelligence capabilities and customer reach across commercial and government markets.

Audax Private Equity Makes Strategic Growth Investment in Integrate

December 20, 2021

Cloud & SaaS

Audax Private Equity completed a strategic growth investment in Integrate (Integrate.com, Inc.), a B2B demand marketing SaaS provider, in December 2021. The undisclosed investment will support Integrate's product development, customer growth, and geographic and vertical expansion for its Demand Acceleration Platform (DAP).

Audax Private Equity Portfolio Company Completes Add-on Acquisition (Undisclosed)

March 6, 2024

Professional Services

Blue River Financial Group advised Audax Private Equity on a recent acquisition completed by one of Audax's portfolio companies. The deal—an add-on—was described as strengthening the portfolio company's footprint across Connecticut and reflects Audax's buy-and-build strategy in the northeast region.

Audax Private Equity Leads Growth Investment in GuidePoint Security

October 10, 2023

Cybersecurity

GuidePoint Security, a Herndon-based cybersecurity solutions provider, closed a growth funding round led by Audax Private Equity with participation from prior investor ABS Capital Partners. The investment will be used to accelerate GuidePoint's U.S. growth and support international expansion; terms were not disclosed.

Audax Private Equity Makes Growth Investment in Pyramid Laboratories, Inc.

April 18, 2023

Pharmaceuticals

Audax Private Equity has made a growth investment in Pyramid Laboratories, Inc., a Costa Mesa, California-based CDMO that provides formulation development, analytical/stability testing, and aseptic fill-finish manufacturing for large-molecule biologics. The capital will support planned facility expansions to increase vial-filling capacity by more than 30% and syringe filling by more than 50%, and to scale Pyramid's clinical and commercial biologics manufacturing and service operations.

Audax Private Equity Acquires Oakbridge Insurance from Corsair

September 26, 2023

Insurance

Audax Private Equity has partnered with Oakbridge's management team to acquire a majority stake in Oakbridge Insurance Agency LLC from Corsair Capital; terms were not disclosed. Audax said it will support Oakbridge's buy-and-build strategy to accelerate growth across the Southeast while Oakbridge's management and employees retain a significant ownership position.